22-24049186-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_012295.4(CABIN1):c.622C>T(p.Leu208Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000172 in 1,613,964 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000072 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00018 ( 3 hom. )
Consequence
CABIN1
NM_012295.4 missense
NM_012295.4 missense
Scores
3
10
6
Clinical Significance
Conservation
PhyloP100: 5.79
Genes affected
CABIN1 (HGNC:24187): (calcineurin binding protein 1) Calcineurin plays an important role in the T-cell receptor-mediated signal transduction pathway. The protein encoded by this gene binds specifically to the activated form of calcineurin and inhibits calcineurin-mediated signal transduction. The encoded protein is found in the nucleus and contains a leucine zipper domain as well as several PEST motifs, sequences which confer targeted degradation to those proteins which contain them. Alternative splicing results in multiple transcript variants encoding two different isoforms. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), CABIN1. . Gene score misZ 1.9223 (greater than the threshold 3.09). Trascript score misZ 3.5534 (greater than threshold 3.09). GenCC has associacion of gene with neurofibromatosis.
BP4
Computational evidence support a benign effect (MetaRNN=0.0828993).
BS2
High Homozygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CABIN1 | NM_012295.4 | c.622C>T | p.Leu208Phe | missense_variant | 7/37 | ENST00000263119.10 | NP_036427.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CABIN1 | ENST00000263119.10 | c.622C>T | p.Leu208Phe | missense_variant | 7/37 | 1 | NM_012295.4 | ENSP00000263119.5 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152236Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
11
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251330Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135850
GnomAD3 exomes
AF:
AC:
26
AN:
251330
Hom.:
AF XY:
AC XY:
13
AN XY:
135850
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000182 AC: 266AN: 1461728Hom.: 3 Cov.: 32 AF XY: 0.000183 AC XY: 133AN XY: 727182
GnomAD4 exome
AF:
AC:
266
AN:
1461728
Hom.:
Cov.:
32
AF XY:
AC XY:
133
AN XY:
727182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74376
GnomAD4 genome
AF:
AC:
11
AN:
152236
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74376
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
13
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 21, 2024 | The c.622C>T (p.L208F) alteration is located in exon 7 (coding exon 6) of the CABIN1 gene. This alteration results from a C to T substitution at nucleotide position 622, causing the leucine (L) at amino acid position 208 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;.;T
Eigen
Uncertain
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M;.;M;.;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N;.;N;N;N
REVEL
Uncertain
Sift
Benign
T;D;.;T;T;D
Sift4G
Pathogenic
D;T;T;T;D;T
Polyphen
1.0, 0.97
.;D;.;.;D;D
Vest4
0.71, 0.41, 0.57, 0.69
MutPred
0.35
.;Loss of catalytic residue at L208 (P = 0.0055);Loss of catalytic residue at L208 (P = 0.0055);Loss of catalytic residue at L208 (P = 0.0055);.;Loss of catalytic residue at L208 (P = 0.0055);
MVP
MPC
1.0
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at